Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 5, 2004, Pages 840-848

  McCarthy, Antonio Desmond ^a   Uemura, Toshimasa ^b   Etcheverry, Susana Beatriz ^a   Cortizo, Ana María ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Advanced glycation endproducts; AGEs; Arg Gly Asp; Asp Gly Glu Ala; DGEA; DMEM; Dulbecco's modified Eagle's medium; ECM; EDTA; Ethylenediamino tetra acetic acid; Extracellular matrix; FBS; Fetal bovine serum; PBS; Phosphate buffered saline solution; RGD

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA INTEGRIN; ALPHA2 INTEGRIN; AMINO ACID; ARGINYLGLYCYLASPARTIC ACID; ASPARTYLGLYCYLGLUTAMYLALANINE; BETA1 INTEGRIN; COLLAGEN TYPE 1; INTEGRIN; INTEGRIN RECEPTOR; PEPTIDE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BETA CHAIN; CELL ADHESION; CELL LINE; CELL SPREADING; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLYCATION; INCUBATION TIME; NONHUMAN; OSTEOBLAST; PROTEIN FUNCTION; RAT;

ANIMALS; BONE MATRIX; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN TYPE I; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; INTEGRINS; OSTEOBLASTS; OSTEOGENESIS; PEPTIDES; RATS;

BOVINAE; CICONIIFORMES;

EID: 1542315275     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.09.006     Document Type: Article

References (34)

1. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 48:1999;1-9.
2. Cortizo A.M., Lettieri M.G., Barrio D.A., Mercer N., Etcheverry S.B., McCarthy A.D. Advanced glycation endproducts (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Molecular and Cellular Biochemistry. 250:2003;1-10.
3. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 289:2000;1501-1504.
4. Katayama Y., Akatsu T., Yamamoto M., Kugai N., Nagata N. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. Journal of Bone and Mineral Research. 11:1996;931-937.
5. Krakauer J.C., McKenna M.J., Buderer N.F., Rao D.S., Whitehouse F.W., Parfitt A.M. Bone loss and bone turnover in diabetes mellitus. Diabetes. 44:1995;775-782.
6. Lavy A., Brook G.J., Dankner G., Amotz A.B., Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism. 40:1991;794-799.
7. Liu Y.K., Nemoto A., Feng Y., Uemura T. The binding ability to matrix proteins and the inhibitory effects on cell adhesion of synthetic peptides derived from a conserved sequence of integrins. Journal of Biochemistry (Tokyo). 121:1997;961-968.
8. Locatto M.E., Abrazon H., Caferra D., Fernández M.C., Alloatti R., Puche R.C. Growth and development of bone mass in untreated alloxan diabetic rats. Effects of collagen glycosylation and parathyroid activity on bone turnover. Bone & Mineral. 23:1993;129-144.
9. McCarthy A.D. Glycation, glycoxidation and carbonyl stress: role in the vascular complications of Diabetes mellitus. Revista Argentina de Endocrinología y Metabolismo. 37:2000;141-163.
10. McCarthy A.D., Cortizo A.M., Giménez Segura G., Bruzzone L., Etcheverry S.B. Non-enzymatic glycosylation of alkaline phosphatase alters its biological properties. Molecular and Cellular Biochemistry. 181:1998;63-69.
11. McCarthy A.D., Etcheverry S.B., Bruzzone L., Lettieri M.G., Barrio D.A., Cortizo A.M. Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress. BioMedCentral Cell Biology. 2:2001;16.
12. McCarthy A.D., Etcheverry S.B., Cortizo A.M. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetologica. 38:2001;113-122.
13. McCarthy A.D., Etcheverry S.B., Bruzzone L., Cortizo A.M. Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Molecular and Cellular Biochemistry. 170:1997;43-51.
14. McCarthy A.D., Etcheverry S.B., Cortizo A.M. Advanced glycation end product specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation. Acta Diabetologica. 36:1999;45-52.
15. Miyata T., Kawai R., Taketomi S., Sprague S.M. Possible involvement of advanced glycation end-products in bone resorption. Nephrology Dialysis Transplantation. 11:1996;54-57.
16. Ng K.W., Romas E., Donnan L., Findlay D.M. Bone biology. Baillères Clinical Endocrinology and Metabolism. 11:1997;1-21.
17. Partridge N.C., Alcorn D., Michelangeli V.P., Ryan G., Martin T.J. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Research. 43:1983;4308-4312.
18. Paul R.G., Avery N.C., Slatter D.A., Sims T.J., Bailey A.J. Isolation and characterisation of advanced glycation end-products derived from the in vitro reaction of ribose and collagen. Biochemical Journal. 330:1998;1241-1248.
19. Paul R.G., Bailey A.J. The effect of advanced glycation end-product formation upon cell-matrix interactions. International Journal of Biochemistry and Cell Biology. 31:1999;653-660.
20. Ruoslahti E. Integrins. Journal of Clinical Investigation. 87:1991;1-5.
21. Sakata N., Sasatomi Y., Meng J., Ando S., Uesugi N., Takebayashi S., Nagai R., Horiuchi S. Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells. Connective Tissue Research. 41:2000;213-228.
22. Sastry C.S.P., Tummuru M.K. Spectrophotometric determination of arginine in proteins. Food Chemistry. 15:1984;257-260.
23. Schenk, R.K., Felix, R., Hofstetter, W. (1993). Morphology of connective tissue: bone. In P. M. Royce, B. Steinmann (Eds.), Connective tissue and its heritable disorders: molecular, genetic and medical aspects (1st ed., pp. 85-101). New York: Wiley.
24. Sun J.J., Zhou X.D., Liu Y.K., Tang Z.Y., Sun R.X., Zhao Y., Uemura T. Inhibitory effects of synthetic beta peptide on invasion and metastasis of liver cancer. Journal of Cancer Research and Clinical Oncology. 126:2000;595-600.
25. Takagi M., Kasayama S., Yamamoto T., Motomura T., Hashimoto K., Yamamoto H., Sato B., Okada S., Kishimoto T. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. Journal of Bone and Mineral Research. 12:1997;439-446.
26. Takeuchi Y., Nakayama K., Matsumoto T. Differentiaton and cell-surface expression of transforming growth factor-β receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. Journal of Biological Chemistry. 271:1996;3938-3944.
27. Tanaka S., Avigad G., Eikenberry E.F., Brodsky B. Isolation and partial characterization of collagen chains dimerized by sugar-derived crosslinks. Journal of Biological Chemistry. 263:1988;17650-17657.
28. Tomasek J.J., Meyers S.W., Basinger J.B., Green D.J., Shew R.L. Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sciences. 55:1994;855-861.
29. Uemura T., Liu Y.K., Feng Y., Nemoto A., Yabe T., Ushida T., Miyamoto H., Tateishi T. The role of sialoproteins in recognition of bone surface by osteoblasts via integrin. Materials Science & Engineering Communications. 4:1997;303-309.
30. Uemura T., Nemoto A., Liu Y.K. Synthetic peptide derived from a conserved sequence of integrin b subunit. Research Advances in Bioscience & Bioengineering. 1:2000;65-83.
31. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma J.W.J., Lafeber F.P.J.G., TeKoppele J.M. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochemical Journal. 350:2000;381-387.
32. Vlassara H. Recent progress in advanced glycation endproducts and diabetic complications. Diabetes. 46(Suppl. 2):1997;S19-S25.
33. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and ageing. Laboratory Investigation. 70:1994;138-151.
34. Yabe T., Nemoto A., Uemura T. Recognition of osteopontin by rat bone marrow derived osteoblastic primary cells. Bioscience Biotechnology & Biochemistry. 61:1997;754-756.